Reevaluating Clinical Trial Design

The New York Academy of Sciences by The New York Academy of Sciences

Oct 20, 201700:49:02Religion & Spirituality

Clinical trials to evaluate new drugs are typically built around one design, the randomized controlled trial, but this method has come under scrutiny in recent years for being expensive, lengthy, and cumbersome. In this...

Related Episodes

Continue listening to more episodes from The New York Academy of Sciences.

Women Who Code A Catalyst for Innovation: Philanthropy in Science and Tech

Jun 20, 2024 - 00:37:30

Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role...

Ethics In Pediatric Research

Dec 13, 2022 - 00:32:31

This podcast highlights discussions from the Ethical Considerations in Research for Pediatric Populations...

The Intersection of Conflicts of Interest and Healthcare

Jun 24, 2021 - 00:41:41

The Intersection of Conflicts of Interest and Healthcare by The New York Academy of Sciences

Big Data: Balancing Privacy and Innovation

Feb 25, 2019 - 00:36:59

Often cited as the "4th Industrial Revolution" big data has the potential to transform health and healthc...

Finding Better Treatments for Children with Cancer

Oct 15, 2018 - 00:31:42

Pediatric cancer is the leading cause of death by disease past infancy among children in the United State...

Discovering New Liver Disease Treatments

Jun 29, 2018 - 00:21:22

Non-alcoholic fatty liver disease is set to become the most common cause of liver transplant in the comin...

Deciphering ZIKA

Apr 11, 2018 - 00:22:18

In 2016, the WHO declared the Zika virus a global medical emergency when, after six decades of dormancy,...

Proof of Concept Centers: Changing Weather

Mar 13, 2018 - 00:20:08

In this episode, we continue to look at some of the fascinating and innovative work that researchers are...